Smith & Nephew SNATS - 27 Year Stock Price History | SNN
Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits and dividends. The latest closing stock price for Smith & Nephew SNATS as of February 11, 2026 is 35.30.
- The all-time high Smith & Nephew SNATS stock closing price was 44.41 on February 20, 2020.
- The Smith & Nephew SNATS 52-week high stock price is 38.79, which is 9.9% above the current share price.
- The Smith & Nephew SNATS 52-week low stock price is 23.91, which is 32.3% below the current share price.
- The average Smith & Nephew SNATS stock price for the last 52 weeks is 31.99.
| Smith & Nephew SNATS Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 33.7721 | 32.8800 | 35.3800 | 31.9000 | 35.3000 | 7.59% |
| 2025 | 30.7225 | 23.8057 | 38.3815 | 23.3081 | 32.8100 | 36.81% |
| 2024 | 26.1726 | 25.4570 | 30.5741 | 22.9693 | 23.9813 | -7.28% |
| 2023 | 26.2286 | 25.1346 | 30.6277 | 20.4320 | 25.8647 | 4.44% |
| 2022 | 26.1667 | 31.4833 | 32.6128 | 19.9591 | 24.7662 | -20.20% |
| 2021 | 34.8469 | 37.7410 | 40.2969 | 28.6685 | 31.0351 | -16.21% |
| 2020 | 35.6073 | 41.5084 | 44.4064 | 23.8886 | 37.0384 | -10.40% |
| 2019 | 36.5299 | 30.7640 | 41.7062 | 30.0118 | 41.3364 | 30.84% |
| 2018 | 30.4464 | 28.9202 | 33.0813 | 27.3834 | 31.5923 | 8.90% |
| 2017 | 28.0543 | 24.3947 | 31.9033 | 24.3215 | 29.0113 | 18.57% |
| 2016 | 26.1065 | 27.7892 | 28.3060 | 22.0520 | 24.4679 | -13.93% |
| 2015 | 27.7314 | 28.2124 | 29.9671 | 25.9366 | 28.4280 | -1.40% |
| 2014 | 25.6112 | 21.8349 | 30.3317 | 21.8349 | 28.8324 | 30.39% |
| 2013 | 18.3175 | 16.7871 | 22.1462 | 15.9347 | 22.1123 | 32.51% |
| 2012 | 15.1335 | 14.4319 | 16.7660 | 13.4519 | 16.6877 | 17.41% |
| 2011 | 15.0373 | 15.2790 | 17.4837 | 12.3574 | 14.2134 | -6.89% |
| 2010 | 13.7817 | 14.7725 | 15.4334 | 11.9134 | 15.2644 | 4.10% |
| 2009 | 11.2707 | 9.1596 | 14.7009 | 8.5892 | 14.6638 | 61.58% |
| 2008 | 15.1289 | 16.0174 | 19.0581 | 8.5387 | 9.0753 | -43.13% |
| 2007 | 16.6828 | 14.4256 | 18.8357 | 14.3429 | 15.9591 | 10.71% |
| 2006 | 12.2050 | 12.9026 | 14.5027 | 10.1330 | 14.4146 | 14.15% |
| 2005 | 13.0030 | 13.7040 | 14.2466 | 10.9683 | 12.6274 | -9.51% |
| 2004 | 13.1837 | 11.1750 | 15.5765 | 10.8972 | 13.9548 | 24.64% |
| 2003 | 8.7837 | 8.1564 | 11.2978 | 7.0673 | 11.1963 | 38.30% |
| 2002 | 7.5955 | 7.8479 | 8.3836 | 6.3490 | 8.0957 | 2.31% |
| 2001 | 6.4446 | 5.9002 | 7.9260 | 5.3679 | 7.9130 | 33.75% |
| 2000 | 4.0843 | 3.4245 | 5.9163 | 2.6189 | 5.9163 | 72.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.032B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| ResMed (RMD) | United States | $38.392B | 25.64 |
| Agilent Technologies (A) | United States | $36.486B | 23.12 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| QuidelOrtho (QDEL) | United States | $1.984B | 12.76 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |